Progress and challenges of the bioartificial pancreas

• Published in: Nano convergence 2016, 3(28), , pp.1-11
• Main Authors: Hwang, Patrick T. J., Shah, Dishant K., Garcia, Jacob A., Bae, Chae Yun, Lim, Dong-Jin, Huiszoon, Ryan C., Alexander, Grant C., Jun, Ho-Wook
• Format: Article
• Language: English
• Subjects: Chemistry and Materials Science; Materials Science; Nanoscale Science and Technology; Nanotechnology; Nanotechnology and Microengineering; Review; 고분자공학
• ISSN: 2196-5404; 2196-5404
• DOI: 10.1186/s40580-016-0088-4

Pancreatic islet transplantation has been validated as a treatment for type 1 diabetes since it maintains consistent and sustained type 1 diabetes reversal. However, one of the major challenges in pancreatic islet transplantation is the body’s natural immune response to the implanted islets. Immunosuppressive drug treatment is the most popular immunomodulatory approach for islet graft survival. However, administration of immunosuppressive drugs gives rise to negative side effects, and long-term effects are not clearly understood. A bioartificial pancreas is a therapeutic approach to enable pancreatic islet transplantation without or with minimal immune suppression. The bioartificial pancreas encapsulates the pancreatic islets in a semi-permeable environment which protects islets from the body’s immune responses, while allowing the permeation of insulin, oxygen, nutrients, and waste. Many groups have developed various types of the bioartificial pancreas and tested their efficacy in animal models. However, the clinical application of the bioartificial pancreas still requires further investigation. In this review, we discuss several types of bioartificial pancreases and address their advantages and limitations. We also discuss recent advances in bioartificial pancreas applications with microfluidic or micropatterning technology.